Nose to Spine: spheroids generated by human nasal chondrocytes for scaffold-free nucleus pulposus augmentation
Source abstract
Abstract
Cell-based strategies for nucleus pulposus (NP) regeneration that adequately support the engraftment and functionality of therapeutic cells are still lacking. This study explores a scaffold-free approach for NP repair, which is based on spheroids derived from human nasal chondrocytes (NC), a resilient cell type with robust cartilage-regenerative capacity. We generated NC spheroids (NCS) in two types of medium (growth or chondrogenic) and analyzed their applicability for NP repair with regard to injectability, biomechanical and biochemical attributes, and integration potential in conditions simulating degenerative disc disease (DDD). NCS engineered in both media were compatible with a typical spinal needle in terms of size (lower than 600µm), shape (roundness greater than 0.8), and injectability (no changes in morphology and catabolic gene expression after passing through the needle). While growth medium ensured stable elastic modulus (E) at 5 kPa, chondrogenic medium time-dependently increased E of NCS, in correlation with gene/protein expression of collagen. Notably, DDD-mimicking conditions did not impair NCS viability nor NCS fusion with NP spheroids simulating degenerated NP in vitro. To assess the feasibility of this approach, NCS were injected into an ex vivo-cultured bovine intervertebral disc (IVD) without damage using a spinal needle. In conclusion, our data indicated that NC cultured as spheroids can be compatible with strategies for minimally invasive NP repair in terms of injectability, tuneability, biomechanical features, and resilience. Future studies will address the capacity of NCS to integrate within degenerated NP under long-term loading conditions. STATEMENT OF SIGNIFICANCE: Current regenerative strategies still do not sufficiently support the engraftment of therapeutic cells in the nucleus pulposus (NP). We present an injectable approach based on spheroids derived from nasal chondrocytes (NC), a resilient cell type with robust cartilage-regenerative capacity. NC spheroids (NCS) generated with their own matrix and demonstrated injectability, tuneability of biomechanical/biochemical attributes, and integration potential in conditions simulating degenerative disc disease. To our knowledge, this is the first study that explored an injectable spheroid-based scaffold-free approach, which showed potential to support the adhesion and viability of therapeutic cells in degenerated NP. The provided information can be of substantial interest to a wide audience, including biomaterial scientists, biomedical engineers, biologists and medical researchers.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Spine and Intervertebral Disc Pathology · Musculoskeletal pain and rehabilitation · Osteoarthritis Treatment and Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (73)
Show source-provided references
1. Advancing cell therapies for intervertebral disc regeneration from the lab to the clinic: recommendations of the ORS spine section10.1002/jsp2.1036 ↗
2. Low back pain10.1038/s41572-018-0052-1 ↗
3. The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain10.1093/rheumatology/ken396 ↗
4. The Epidemiology of low back pain, best practice & research
5. Prognosis in patients with recent onset low back pain in Australian primary care: inception cohort study10.1136/bmj.a171 ↗
6. Long-term outcomes of lumbar fusion among workers’ compensation subjects: a historical cohort study10.1097/BRS.0b013e3181ccc220 ↗
7. Comparison of artificial total disc replacement versus fusion for lumbar degenerative disc disease: a meta-analysis of randomized controlled trials10.1007/s00264-013-1883-8 ↗
8. Stem cell therapy for intervertebral disc regeneration: obstacles and solutions10.1038/nrrheum.2015.13 ↗
9. Cell therapy for intervertebral disc herniation and degenerative disc disease: clinical trials10.1007/s00264-018-4223-1 ↗
10. Efficacy of intervertebral disc regeneration with stem cells - a systematic review and meta-analysis of animal controlled trials10.1016/j.gene.2015.03.022 ↗
11. Intervertebral disc tissue engineering: a brief review
12. Interaction between mesenchymal stem cells and intervertebral disc microenvironment: from cell therapy to tissue engineering10.1155/2019/2376172 ↗
13. Microenvironmental control of disc cell function: influence of hypoxia and osmotic pressure10.1007/978-3-7091-1535-0_6 ↗
14. MSC response to pH levels found in degenerating intervertebral discs10.1016/j.bbrc.2008.12.145 ↗
15. Nose to back: compatibility of nasal chondrocytes with environmental conditions mimicking a degenerated intervertebral disc10.22203/eCM.v037a13 ↗
16. Performance of nasal chondrocytes in an osteoarthritic environment10.1016/j.joca.2018.02.091 ↗
17. Adult human neural crest-derived cells for articular cartilage repair10.1126/scitranslmed.3009688 ↗
18. Regenerative potential of tissue-engineered nasal chondrocytes in goat articular cartilage defects10.1089/ten.tea.2016.0159 ↗
19. Nasal chondrocyte-based engineered autologous cartilage tissue for repair of articular cartilage defects: an observational first-in-human trial10.1016/S0140-6736(16)31658-0 ↗
20. Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: an observational first-in-human trial10.1016/S0140-6736(14)60544-4 ↗
21. Biomaterials for intervertebral disc regeneration and repair10.1016/j.biomaterials.2017.03.013 ↗
22. Biomaterials for intervertebral disc regeneration: current status and looming challenges10.1002/term.2750 ↗
23. Mesenchymal stem cells injection in degenerated intervertebral disc: cell leakage may induce osteophyte formation10.1002/term.433 ↗
24. Emergence of scaffold-free approaches for tissue engineering musculoskeletal cartilages10.1007/s10439-014-1161-y ↗
25. Mesenchymal stem cells injection in degenerated intervertebral disc: cell leakage may induce osteophyte formation10.1002/term.433 ↗
26. The Self-Assembling Process and Applications in Tissue Engineering10.1101/cshperspect.a025668 ↗
27. Scaffold-free, stem cell-based cartilage repair10.1016/j.jcot.2016.06.002 ↗
28. Quantification of the forces driving self-assembly of three-dimensional microtissues10.1073/pnas.1102559108 ↗
29. In vitro engineering of human autogenous cartilage10.1359/jbmr.2002.17.8.1420 ↗
30. Adult stem cells spheroids to optimize cell colonization in scaffolds for cartilage and bone tissue engineering10.3390/ijms19051285 ↗
31. One-year clinical and radiological results of a prospective, investigator-initiated trial examining a novel, purely autologous 3-dimensional autologous chondrocyte transplantation product in the knee10.1177/1947603511417616 ↗
32. Good clinical and MRI outcome after arthroscopic autologous chondrocyte implantation for cartilage repair in the knee10.1007/s00167-017-4491-0 ↗
33. An ex vivo human cartilage repair model to evaluate the potency of a cartilage cell transplant10.1186/s12967-016-1065-8 ↗
34. Multiparametric analysis of tissue spheroids fabricated from different types of cells10.1002/biot.201900217 ↗
35. Visual histological grading system for the evaluation of in vitro-generated neocartilage10.1089/ten.2006.12.2141 ↗
36. Synovial fluid concentrations of the C-propeptide of type II collagen correlate with body mass index in primary knee osteoarthritis10.1136/ard.56.8.500 ↗
37. Cytoskeleton systems contribute differently to the functional intrinsic properties of chondrospheres10.1016/j.actbio.2020.10.007 ↗
38. Papain-induced in vitro disc degeneration model for the study of injectable nucleus pulposus therapy10.1016/j.spinee.2012.12.007 ↗
39. Papain-induced in vitro disc degeneration model for the study of injectable nucleus pulposus therapy10.1016/j.spinee.2012.12.007 ↗
40. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier10.1016/j.biomaterials.2005.03.001 ↗
41. Inflammatory mediators in intervertebral disk degeneration and discogenic pain10.1055/s-0033-1347299 ↗
42. Fluid shear stress-induced osteoarthritis: roles of cyclooxygenase-2 and its metabolic products in inducing the expression of proinflammatory cytokines and matrix metalloproteinases10.1096/fj.13-234542 ↗
43. Effects of degeneration on the elastic modulus distribution in the lumbar intervertebral disc10.1097/00007632-199604010-00007 ↗
44. Alterations in the mechanical behavior of the human lumbar nucleus pulposus with degeneration and aging10.1002/jor.1100150224 ↗
45. Postnatal changes to the mechanical properties of articular cartilage are driven by the evolution of its collagen network10.22203/eCM.v029a09 ↗
46. Aggrecan nanoscale solid-fluid interactions are a primary determinant of cartilage dynamic mechanical properties10.1021/nn5062707 ↗
47. Extracellular matrix determines biomechanical properties of chondrospheres during their maturation in vitro10.1177/1947603518798890 ↗
48. Critical aspects and challenges for intervertebral disc repair and regeneration-Harnessing advances in tissue engineering10.1002/jsp2.1029 ↗
49. Current treatment options for intervertebral disc pathologies10.1177/1947603520907665 ↗
50. In vitro extracellular matrix accumulation of nasal and articular chondrocytes for intervertebral disc repair10.1016/j.tice.2017.05.002 ↗
51. Identifying and managing sources of variability in cell therapy manufacturing and clinical trials10.1007/s40883-019-00129-y ↗
52. Platelet-rich plasma obtained with different anticoagulants and their effect on platelet numbers and mesenchymal stromal cells behavior in vitro10.1155/2016/7414036 ↗
53. Platelet-rich plasma can replace fetal bovine serum in human meniscus cell cultures10.1089/ten.tec.2013.0009 ↗
54. IL-1ra delivered from poly(lactic-co-glycolic acid) microspheres attenuates IL-1beta-mediated degradation of nucleus pulposus in vitro10.1186/ar3932 ↗
55. Drug delivery in intervertebral disc degeneration and osteoarthritis: Selecting the optimal platform for the delivery of disease-modifying agents10.1016/j.jconrel.2020.08.041 ↗
56. Randomized, open-label, multicenter, phase iii noninferiority trial to compare the clinical efficacy of matrix-associated autologous chondrocyte implantation with spheroid technology versus arthroscopic microfracture for cartilage defects of the knee10.1177/2325967119854442 ↗
57. Multifactorial experimental design to optimize the anti-inflammatory and proangiogenic potential of mesenchymal stem cell spheroids10.1002/stem.2606 ↗
58. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors10.1089/adt.2014.573 ↗
59. Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc10.22203/eCM.v008a06 ↗
60. Material properties in unconfined compression of human nucleus pulposus, injectable hyaluronic acid-based hydrogels and tissue engineering scaffolds10.1007/s00586-007-0443-6 ↗
61. ‘Stress’ distributions inside intervertebral discs. The effects of age and degeneration10.1302/0301-620X.78B6.0780965 ↗
62. Biomechanics of the human intervertebral disc: a review of testing techniques and results10.1016/j.jmbbm.2017.01.037 ↗
63. Immunolocalization of major interstitial collagen types in human lumbar intervertebral discs of various ages10.1007/s004280050136 ↗
64. Precultivation of engineered human nasal cartilage enhances the mechanical properties relevant for use in facial reconstructive surgery10.1097/01.sla.0000247057.16710.be ↗
65. Ascorbic acid uptake and regulation of type I collagen synthesis in cultured vascular smooth muscle cells10.1159/000135661 ↗
66. Proliferation as a requirement for in vitro chondrogenesis of human mesenchymal stem cells10.1089/scd.2011.0670 ↗
67. Validation of a high-throughput microtissue fabrication process for 3D assembly of tissue engineered cartilage constructs10.1007/s00441-011-1311-6 ↗
68. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow10.1111/j.1532-950X.2008.00462.x ↗
69. Metabolism of the intervertebral disc: effects of low levels of oxygen, glucose, and pH on rates of energy metabolism of bovine nucleus pulposus cells10.1097/01.brs.0000154619.38122.47 ↗
70. A role for TNF alpha in intervertebral disc degeneration: a non-recoverable catabolic shift10.1016/j.bbrc.2013.02.034 ↗
71. Quantifying the kinetics and morphological changes of the fusion of spheroid building blocks10.1088/1758-5090/8/4/045003 ↗
72. Production of three-dimensional tissue-engineered cartilage through mutual fusion of chondrocyte pellets10.1016/j.ijom.2016.03.002 ↗
73. Stem cell therapy for intervertebral disc regeneration: obstacles and solutions10.1038/nrrheum.2015.13 ↗